These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 21615170)

  • 1. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
    Ashley CE; Carnes EC; Phillips GK; Durfee PN; Buley MD; Lino CA; Padilla DP; Phillips B; Carter MB; Willman CL; Brinker CJ; Caldeira Jdo C; Chackerian B; Wharton W; Peabody DS
    ACS Nano; 2011 Jul; 5(7):5729-45. PubMed ID: 21615170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform.
    Galaway FA; Stockley PG
    Mol Pharm; 2013 Jan; 10(1):59-68. PubMed ID: 23110441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.
    Peabody DS; Manifold-Wheeler B; Medford A; Jordan SK; do Carmo Caldeira J; Chackerian B
    J Mol Biol; 2008 Jun; 380(1):252-63. PubMed ID: 18508079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Thermal Stability of Bacteriophage MS2-Derived Virus-like Particle and Its Engineered Variant.
    Vishwakarma P; Puri S; Banerjee M; Chang CY; Chang CC; Chaudhuri TK
    ACS Biomater Sci Eng; 2024 Aug; 10(8):4812-4822. PubMed ID: 38976823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models.
    Aanei IL; ElSohly AM; Farkas ME; Netirojjanakul C; Regan M; Taylor Murphy S; O'Neil JP; Seo Y; Francis MB
    Mol Pharm; 2016 Nov; 13(11):3764-3772. PubMed ID: 27611245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MS2 Virus-like Particles as a Versatile Peptide Presentation Platform: Insights into the Deterministic Abilities for Accommodating Heterologous Peptide Lengths.
    Dang M; Wu LJ; Zhang SR; Zhu JR; Hu YZ; Yang CX; Zhang XY
    ACS Synth Biol; 2023 Dec; 12(12):3704-3715. PubMed ID: 37946498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.
    Tumban E; Peabody J; Tyler M; Peabody DS; Chackerian B
    PLoS One; 2012; 7(11):e49751. PubMed ID: 23185426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.
    Chang L; Wang G; Jia T; Zhang L; Li Y; Han Y; Zhang K; Lin G; Zhang R; Li J; Wang L
    Oncotarget; 2016 Apr; 7(17):23988-4004. PubMed ID: 26992211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Display of single-chain variable fragments on bacteriophage MS2 virus-like particles.
    Lino CA; Caldeira JC; Peabody DS
    J Nanobiotechnology; 2017 Feb; 15(1):13. PubMed ID: 28193211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Surface Modification of Genome-Free MS2 Capsids for Delivery Applications.
    Aanei IL; Francis MB
    Methods Mol Biol; 2018; 1776():629-642. PubMed ID: 29869270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel delivery platform based on Bacteriophage MS2 virus-like particles.
    Fu Y; Li J
    Virus Res; 2016 Jan; 211():9-16. PubMed ID: 26415756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.
    Wei B; Wei Y; Zhang K; Wang J; Xu R; Zhan S; Lin G; Wang W; Liu M; Wang L; Zhang R; Li J
    Biomed Pharmacother; 2009 May; 63(4):313-8. PubMed ID: 18823738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.
    Wang G; Jia T; Xu X; Chang L; Zhang R; Fu Y; Li Y; Yang X; Zhang K; Lin G; Han Y; Li J
    Oncotarget; 2016 Sep; 7(37):59402-59416. PubMed ID: 27449085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells.
    Naskalska A; Heddle JG
    Nanomedicine (Lond); 2024; 19(12):1103-1115. PubMed ID: 38629576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-specific delivery of bacteriophage-encapsidated ricin A chain.
    Wu M; Brown WL; Stockley PG
    Bioconjug Chem; 1995; 6(5):587-95. PubMed ID: 8974458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of internal RNA on aggregation and electrokinetics of viruses: comparison between MS2 phage and corresponding virus-like particles.
    Dika C; Duval JF; Ly-Chatain HM; Merlin C; Gantzer C
    Appl Environ Microbiol; 2011 Jul; 77(14):4939-48. PubMed ID: 21622784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal stability of RNA phage virus-like particles displaying foreign peptides.
    Caldeira JC; Peabody DS
    J Nanobiotechnology; 2011 May; 9():22. PubMed ID: 21609437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.
    Pan Y; Zhang Y; Jia T; Zhang K; Li J; Wang L
    FEBS J; 2012 Apr; 279(7):1198-208. PubMed ID: 22309233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the synthesis and purification of MS2 virus like particles.
    Hashemi K; Ghahramani Seno MM; Ahmadian MR; Malaekeh-Nikouei B; Bassami MR; Dehghani H; Afkhami-Goli A
    Sci Rep; 2021 Oct; 11(1):19851. PubMed ID: 34615923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA bacteriophage capsid-mediated drug delivery and epitope presentation.
    Brown WL; Mastico RA; Wu M; Heal KG; Adams CJ; Murray JB; Simpson JC; Lord JM; Taylor-Robinson AW; Stockley PG
    Intervirology; 2002; 45(4-6):371-80. PubMed ID: 12602361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.